These genes, namely CTNNB1, HDAC1, CREBBP, PIK3R1, PRKACA, MAPK14, NR3C1, GNAQ, STAT3, and DCN, have previous implications in lung cancer, serving as potential early diagnostic and therapeutic biomarkers (19–23). This evidence concerns the gene GNAQ and lung cancer.